MétaCan
Menu
Back to cohort
Record W3136470807 · doi:10.1042/bio_2021_125

Hello from the new Science Editor

2021· article· en· W3136470807 on OpenAlexaboutno aff
Heather Doran

Bibliographic record

VenueThe Biochemist · 2021
Typearticle
Languageen
FieldMedicine
TopicDiabetes Management and Research
Canadian institutionsnot available
Fundersnot available
KeywordsPandemicBiochemistMedicineCoronavirus disease 2019 (COVID-19)HistoryGerontologyDiseaseClassicsInfectious disease (medical specialty)Internal medicine

Abstract

fetched live from OpenAlex

We are now well into 2021, and the COVID-19 vaccination roll-out is in progress, but we are still trying to handle a global pandemic. I hope people take heart from this issue that looks back 100 years, and to the future, to celebrate the discovery of insulin and how this paved the way for saving millions of lives globally. Diabetes is still a disease that has no cure but our knowledge of its biochemistry means it is now manageable and this has transformed the lives of those with the disease within an extremely short period of time.I want to speak about this discovery at the start of this special themed issue. The first use of insulin for treatment of type 1 diabetes in humans was in January 1922, less than 12 months after it had been first successfully extracted by surgeon Sir Frederick Banting and physiologist Charles Best in the labs of Professor John MacLeod at the University of Toronto. James Collip, a Canadian biochemist, had joined the team in Toronto and was able to help concentrate and extract a purer form of insulin from cattle which could then be used in humans.The first treatment involved two injections of insulin that were given to Leonard Thompson, a 14-year-old boy and, for the first time, they were able to lower high blood sugar and he recovered. As is the case with most scientific discoveries, it involved knowledge and input from multiple people to enable people around the world to be treated by insulin. The Nobel Prize was awarded to Banting and Macleod in 1923 with Banting then splitting half of his prize money with Best and Macleod splitting his half with Collip.We are still learning about diabetes today, and with higher numbers of people being diagnosed with type 2 diabetes, it is important to continue the search for a cure for the disease.I am humbled that this is the theme for my first issue of The Biochemist and I want to thank the previous editor Chris Willmott for confirming this as a theme and for his work with The Biochemist over the past few years. The magazine has introduced new features and now has a more easily accessible online presence. I hope that I can maintain the high standard that has been set, and continue to grow the publication.The role of molecular bioscience in society has never been in more focus than it has been over the past 12 months and I want to ensure that The Biochemist continues to highlight the importance of that work.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.024
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: Editorial
Teacher disagreement score0.093
Threshold uncertainty score0.311

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.024
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0020.001
Scholarly communication0.0080.005
Open science0.0020.003
Research integrity0.0060.011
Insufficient payload (model declined to judge)0.0930.051

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.292
Teacher spread0.277 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueThe BiochemistSame topicDiabetes Management and ResearchFrench-language works237,207